224 related articles for article (PubMed ID: 33847822)
1. The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer.
Xu L; Li C; Hua F; Liu X
Med Oncol; 2021 Apr; 38(5):58. PubMed ID: 33847822
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer.
Long P; Sun F; Ma Y; Huang Y
Tumour Biol; 2016 Jun; 37(6):7473-80. PubMed ID: 26678890
[TBL] [Abstract][Full Text] [Related]
4. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.
Wani N; Nasser MW; Ahirwar DK; Zhao H; Miao Z; Shilo K; Ganju RK
Breast Cancer Res; 2014 May; 16(3):R54. PubMed ID: 24886617
[TBL] [Abstract][Full Text] [Related]
5. CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.
Chen N; Jiang X; Wang J; Wu T; Cheng B; Xia J
Tumour Biol; 2016 Jan; 37(1):567-75. PubMed ID: 26232325
[TBL] [Abstract][Full Text] [Related]
6. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.
Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L
Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564
[TBL] [Abstract][Full Text] [Related]
7. CXCR7/CXCL12 axis is involved in lymph node and liver metastasis of gastric carcinoma.
Xin Q; Zhang N; Yu HB; Zhang Q; Cui YF; Zhang CS; Ma Z; Yang Y; Liu W
World J Gastroenterol; 2017 May; 23(17):3053-3065. PubMed ID: 28533662
[TBL] [Abstract][Full Text] [Related]
8. The role of the SDF-1/ CXCR7 axis on the growth and invasion ability of endometrial cancer cells.
Gu HQ; Zhang ZB; Zhang JW; Wang QQ; Xi XW; He YY
Arch Gynecol Obstet; 2017 Apr; 295(4):987-995. PubMed ID: 28239742
[TBL] [Abstract][Full Text] [Related]
9. CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells.
Choi YH; Burdick MD; Strieter BA; Mehrad B; Strieter RM
Mol Cancer Res; 2014 Jan; 12(1):38-47. PubMed ID: 24025971
[TBL] [Abstract][Full Text] [Related]
10. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD
Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857
[TBL] [Abstract][Full Text] [Related]
11. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
12. CXCR7 expression correlates with tumor depth in cutaneous squamous cell carcinoma skin lesions and promotes tumor cell survival through ERK activation.
Hu SC; Yu HS; Yen FL; Chen GS; Lan CC
Exp Dermatol; 2014 Dec; 23(12):902-8. PubMed ID: 25256412
[TBL] [Abstract][Full Text] [Related]
13. Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo.
Meijer J; Ogink J; Roos E
Br J Cancer; 2008 Nov; 99(9):1493-501. PubMed ID: 18854833
[TBL] [Abstract][Full Text] [Related]
14. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
Khare T; Bissonnette M; Khare S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
[TBL] [Abstract][Full Text] [Related]
15. The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma.
Li T; Li H; Wang Y; Harvard C; Tan JL; Au A; Xu Z; Jablons DM; You L
J Pathol; 2011 Mar; 223(4):519-30. PubMed ID: 21294125
[TBL] [Abstract][Full Text] [Related]
16. Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.
Hernandez L; Magalhaes MA; Coniglio SJ; Condeelis JS; Segall JE
Breast Cancer Res; 2011; 13(6):R128. PubMed ID: 22152016
[TBL] [Abstract][Full Text] [Related]
17. CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer.
Guo JC; Li J; Zhou L; Yang JY; Zhang ZG; Liang ZY; Zhou WX; You L; Zhang TP; Zhao YP
Oncotarget; 2016 Sep; 7(38):62006-62018. PubMed ID: 27542220
[TBL] [Abstract][Full Text] [Related]
18. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.
Shakir M; Tang D; Zeh HJ; Tang SW; Anderson CJ; Bahary N; Lotze MT
Pancreas; 2015 May; 44(4):528-34. PubMed ID: 25872129
[TBL] [Abstract][Full Text] [Related]
19. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
Zabel BA; Wang Y; Lewén S; Berahovich RD; Penfold ME; Zhang P; Powers J; Summers BC; Miao Z; Zhao B; Jalili A; Janowska-Wieczorek A; Jaen JC; Schall TJ
J Immunol; 2009 Sep; 183(5):3204-11. PubMed ID: 19641136
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
